Cargando…

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With None–Small-cell Lung Cancer

Immunotherapy is a mainstay of treatment for nonesmall-cell lung cancer. Serious immune-related adverse events (irAEs) occur; however, their effect on survival is unclear, and no defined risks factors have been elucidated. In the present study, we found no significant effect of irAE on survival in a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owen, Dwight H., Wei, Lai, Bertino, Erin M., Edd, Thomas, Villalona-Calero, Miguel A., He, Kai, Shields, Peter G., Carbone, David P., Otterson, Gregory A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193681/ https://www.ncbi.nlm.nih.gov/pubmed/30197259 http://dx.doi.org/10.1016/j.cllc.2018.08.008

Ejemplares similares

Association Between RBC Antigen Allo-Antibodies and Immune-Related Adverse Events During Immune Checkpoint Inhibitor Treatment for Advanced Cancers
por: Jain, Natasha A, et al.
Publicado: (2020)

Immune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survival
por: Haddad, Tyler C., et al.
Publicado: (2021)

Fanconi Anemia Repair Pathway Dysfunction, a Potential Therapeutic Target in Lung Cancer
por: Duan, Wenrui, et al.
Publicado: (2014)

Change in neutrophil to lymphocyte ratio during immunotherapy treatment is a non-linear predictor of patient outcomes in advanced cancers
por: Li, Mingjia, et al.
Publicado: (2019)

Coherence Potentials: Loss-Less, All-or-None Network Events in the Cortex
por: Thiagarajan, Tara C., et al.
Publicado: (2010)

Overexpression of Rad51C splice variants in colorectal tumors
por: Kalvala, Arjun, et al.
Publicado: (2014)

None
Publicado: (1999)

Emerging biomarkers for checkpoint inhibitors in thymic epithelial tumors
por: Owen, Dwight H., et al.
Publicado: (2019)

Correction: Coherence Potentials: Loss-Less, All-or-None Network Events in the Cortex
por: Thiagarajan, Tara C., et al.
Publicado: (2010)

Correction: Coherence Potentials: Loss-Less, All-or-None Network Events in the Cortex
por: Thiagarajan, Tara C., et al.
Publicado: (2010)

Podcast on the Management of Adverse Events Associated with Lorlatinib
por: Bauer, Todd M., et al.
Publicado: (2022)

And then there were none
por: Christie, Agatha, 1890-1976

And then there were none
por: Silva, Jose Tiago, et al.
Publicado: (2019)

Advances in epigenetic therapeutics with focus on solid tumors
por: Jin, Ning, et al.
Publicado: (2021)

United We Fall: All-or-None Forgetting of Complex Episodic Events
por: Joensen, Bárður H., et al.
Publicado: (2019)

Expression of a Mutant p53 Results in an Age-Related Demographic Shift in Spontaneous Lung Tumor Formation in Transgenic Mice
por: Duan, Wenrui, et al.
Publicado: (2009)

None Too Much Quarantine
Publicado: (1885)

With charity toward none : a fond look at misanthropy
por: King, Florence
Publicado: (1993)

Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer
por: Zhao, Weiqiang, et al.
Publicado: (2012)

Myocardial Infarction as an Initial Presentation of Essential Thrombocythemia With Calreticulin (CALR) Mutation (None Type 1, None Type 2)
por: Afana, Mohammad, et al.
Publicado: (2023)

Assessment of Effective Network Connectivity among MEG None Contaminated Epileptic Transitory Events
por: Hadriche, Abir, et al.
Publicado: (2021)

On the all-or-none rule of conscious perception
por: Bachmann, Talis
Publicado: (2013)

Business without ethics is good for none
por: Gupta, Harish, et al.
Publicado: (2022)

Second chances – better than none
por: Liesveld, Jane
Publicado: (2023)

Identifying patterns of care for elderly patients with non-surgically treated stage III non-small cell lung cancer: an analysis of the national cancer database
por: Miller, Eric D, et al.
Publicado: (2018)

Clinical and Metabolic Parameters in Non-Small Cell Lung Carcinoma and Colorectal Cancer Patients with and without KRAS Mutations
por: Yilmaz, Ahmet, et al.
Publicado: (2014)

Cellular localization of protein arginine methyltransferase-5 correlates with grade of lung tumors
por: Shilo, Konstantin, et al.
Publicado: (2013)

Degranulation of individual mast cells in response to Ca2+ and guanine nucleotides: an all-or-none event
Publicado: (1993)

cis-2,6-Dibenzylcyclohexanone
por: Culver, John P., et al.
Publicado: (2009)

The estimation of genetic parameters for all-or-none traits
por: Rønningen, K
Publicado: (1976)

Prognostic scores for hepatocellular carcinoma: none is the winner
por: Cammà, Calogero, et al.
Publicado: (2009)

Quantifying western blots: none more black
por: Bell, Graham
Publicado: (2016)

The Vacant Secretaryship at Norwich: Hundreds of Applications or None?
Publicado: (1915)

The lemon illusion: seeing curvature where there is none
por: Strother, Lars, et al.
Publicado: (2015)

Yo-yo dieting is better than none
por: Di Germanio, Clara, et al.
Publicado: (2018)

Increased NQO1 but Not c-MET and Survivin Expression in Non-Small Cell Lung Carcinoma with KRAS Mutations
por: Yilmaz, Ahmet, et al.
Publicado: (2014)

Rad51C-ATXN7 fusion gene expression in colorectal tumors
por: Kalvala, Arjun, et al.
Publicado: (2016)

Haemolymph Components of Infected & None Infected Lymnaea snails with Xiphidiocercariae
por: Saboor Yaraghi, AA, et al.
Publicado: (2011)

24-Month-Olds’ Selective Learning Is Not an All-or-None Phenomenon
por: Henderson, Annette M. E., et al.
Publicado: (2015)

Cyclohexanone 2-nitrophenylhydrazone
por: Yang, Bao-he, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_gmm3uu3d0o0e507g950enssueh